Vergoeding 2017-2021 voor ATC-subgroep A10AB : Snelwerkende insulines voor injectie
- Raming voor de totale Zvw-populatie
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| A10AB01 Insuline (humaan) (Insuman rapid ®) | 557.990 | 486.270 | 434.450 | 387.290 | 339.120 |
| A10AB04 Insuline lispro (Humalog ®) | 7.076.400 | 6.860.100 | 6.625.800 | 6.199.300 | 5.487.200 |
| A10AB05 Insuline aspart (Novorapid ®) | 45.338.800 | 44.937.800 | 44.948.900 | 43.825.600 | 38.614.900 |
| A10AB06 Insuline glulisine (Apidra ®) | 3.839.900 | 3.669.700 | 3.430.400 | 3.191.100 | 2.889.000 |
| Totaal | 56.813.090 | 55.953.870 | 55.439.550 | 53.603.290 | 47.330.220 |